✦ LIBER ✦

On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy

✍ Scribed by P.A. van Doorn; F. Rossi; A. Brand; M. van Lint; M. Vermeulen; M.D. Kazatchkine

Book ID: 119107612
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 600 KB
Volume: 29
Category: Article
ISSN: 0165-5728
DOI: 10.1016/0165-5728(90)90147-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic inflammatory demyel

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin

✍ Dr. David R. Cornblath; Vinay Chaudhry; John W. Griffin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

## Abstract Chronic inflammatory demyelinating polyneuropathy is an immune‐mediated demyelinating peripheral neuropathy usually treated with immunosuppressants. We reviewed our experience treating 15 patients (9 men, 6 women) with intravenous immunoglobulin. Six patients were on other therapies at

Dose of intravenous immunoglobulins in c

Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy

✍ Yusuf A. Rajabally; Hanny Seow; Patrick Wilson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Neurophysiological assessment of the eff

Neurophysiological assessment of the effects of high-dose i.v. immunoglobulin treatment in 9 patients with chronic inflammatory demyelinating polyneuropathy

✍ S. Amadio; G. Galardi; E. Bianchi; L. Maderna; F. Riti; R. Fazio; R. Nemni; G. C 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Intravenous immunoglobulin treatment in

Intravenous immunoglobulin treatment in patients with a chronic inflammatory demyelinating polyneuropathy Clinical and laboratory factors associated with improvement

✍ van Doom, P.A.; Vermeulen, M.; Busch, H.F.M.; Brand, A. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Intravenous immunoglobulin inhibits BAFF

Intravenous immunoglobulin inhibits BAFF production in chronic inflammatory demyelinating polyneuropathy — A new mechanism of action?

✍ Bick, Sandra; Tschernatsch, Marlene; Karg, Anne; Fuehlhuber, Verena; Trenczek, T 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 548 KB

The efficacy of subcutaneous immunoglobu

The efficacy of subcutaneous immunoglobulin administration in chronic inflammatory demyelinating polyneuropathy responders to intravenous immunoglobulin

✍ Dario Cocito; Grazia Serra; Yolanda Falcone; Ilaria Paolasso 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB